Zurück zum Inhalt

Geburtshilfe

Management einer Thrombozytopenie

Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. (öffnet neues Fenster)

Decroocq J, Marcellin L, Le Ray C, Willems L.

Quelle‎: Obstet Gynecol 2014;124(2 Pt 2 Suppl 1):481-3.

Indiziert‎: PubMed 25004319

DOI‎: 10.1097/AOG.0000000000000371

https://www.ncbi.nlm.nih.gov/pubmed/25004319 (öffnet neues Fenster)

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study. (öffnet neues Fenster)

Michel M, Ruggeri M, Gonzalez-Lopez TJ, Alkindi SS, Cheze S, Ghanima W, Tvedt THA, Ebbo M, Terriou L, Bussel JB, Godeau B

Quelle‎: Blood 2020;136(26):3056-61.

Indiziert‎: PubMed 32814348

DOI‎: 10.1182/blood.2020007594

https://www.ncbi.nlm.nih.gov/pubmed/32814348 (öffnet neues Fenster)

A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopag. (öffnet neues Fenster)

Purushothaman J, Puthumana KJ, Kumar A, Innah SJ, Gilvaz S.

Quelle‎: Asian J Transfus Sci 2016;10(2):155-8.

Indiziert‎: PubMed 27605856

DOI‎: 10.4103/0973-6247.177204

https://www.ncbi.nlm.nih.gov/pubmed/27605856 (öffnet neues Fenster)

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. (öffnet neues Fenster)

Saleh MN, Bussel JB, Cheng G, Meyer O, Bailey CK, Arning M, Brainsky A; EXTEND Study Group.

Quelle‎: Blood 2013;121(3):537-45.

Indiziert‎: PubMed 23169778

https://www.ncbi.nlm.nih.gov/pubmed/23169778 (öffnet neues Fenster)